Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06381115 · ClinicalTrials.gov registry record · NA

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

A NA study of Obstructive Sleep Apnea, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06381115 is a NA study of Obstructive Sleep Apnea that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06381115, a NA study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. This application aims to target CPAP adherence.

Conditions Studied

Interventions

  • BEHAVIORAL SleepWell24 Application

Study Locations (2)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-01
Est. Completion 2026-07
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06381115

The ClinicalTrials.gov registry entry for NCT06381115 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (82% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which SleepWell24 Application is the first listed.

NCT06381115 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06381115 about?

NCT06381115 is a clinical study titled "App-Based Optimization of Long-Term CPAP Adherence and Quality of Life". The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. This application aims to target CPAP adherence.

What is the current status of trial NCT06381115?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-01. Estimated completion is 2026-07.

What conditions does trial NCT06381115 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT06381115?

The interventions under investigation include: SleepWell24 Application (BEHAVIORAL).

Who is sponsoring clinical trial NCT06381115?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06381115 being conducted?

This trial has 2 study locations across Arizona, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.